Pomalidomide Synthesis via Segmented Imide Formation and Crystallization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing pomalidomide often result in lower yields and purities, making them less efficient and more costly for large-scale production, particularly in achieving the required high purity for pharmaceutical applications.
Innovation Solution
A process involving the reaction of nitro phthalic acid with 3-amino-piperidine-2,6-dione in the presence of a coupling agent and solvent to form 3-(3-nitrophthalimido)-piperidine-2,6-dione, followed by reduction to obtain pomalidomide, along with a purification method using solvent and anti-solvent to achieve high yield and purity greater than 99%.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional methods are used for preparing pomalidomide, then the process is simpler, but the yield and purity are lower
Solution Approach 1:
The synthesis process is divided into distinct stages: first forming the imide intermediate, then reducing the nitro group, and finally purifying through controlled crystallization. Each stage is optimized independently to achieve cumulative improvements in purity and yield that would not be possible with conventional single-step approaches.
Solution Approach 2:
The invention optimizes specific parameters including the coupling agent selection (EDC/DMAP), solvent system (DMF/DCM), reduction conditions (SnCl2 in HCl), and crystallization parameters (acetone/water ratio, temperature profile). These parameter changes collectively achieve >99% purity while maintaining reasonable process complexity.
2Productivity
If conventional preparation methods are used, then the process is easier to implement, but the yield is lower
Solution Approach 1:
The method performs preliminary optimization of the imide formation step using EDC/DMAP coupling under controlled conditions to ensure high conversion before proceeding to reduction. This preliminary action prevents carryover of unreacted starting materials that would complicate subsequent steps and reduce overall yield.
Solution Approach 2:
The invention uses specific intermediary compounds and reagents: EDC as a coupling mediator, DMAP as a catalyst, and SnCl2 as a reducing intermediary. These intermediaries facilitate high-yield transformations while their well-defined chemistry makes the process easier to implement and control at scale.
3Manufacturing precision
If conventional purification methods are used, then the process is simpler, but the purity is insufficient for pharmaceutical applications
Solution Approach 1:
The purification strategy exploits phase transitions through controlled crystallization. By adjusting solvent composition (acetone/water) and temperature, the product transitions from dissolved to crystalline state, selectively separating it from impurities. This phase-based purification achieves >99% purity efficiently without requiring multiple complex purification steps.
Solution Approach 2:
The invention employs inexpensive, readily available solvents and reagents for purification (acetone, water, ethyl acetate) that can be easily removed. These disposable solvents enable simple filtration and evaporation steps rather than requiring complex, time-consuming chromatographic or distillation procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves high yield and purity of pomalidomide, facilitating large-scale production and pharmaceutical dosage forms with enhanced efficacy for treating multiple myeloma, specifically providing a purity greater than 99.7% and suitable for patients who have received prior therapies.
Implementation Method 1
reacting nitro phthalic acid with 3-amino-piperidine-2,6-dione or its salt in the presence of a coupling agent and a suitable solvent to obtain 3-(3-nitrophthalimido)-piperidine-2,6-dione
Implementation Method 2
reducing 3-(3-nitrophthalimido)-piperidine-2,6-dione in the presence of a solvent and catalyst to obtain pomalidomide
Implementation Method 3
reducing 3-(3-nitrophthalimido)-piperidine-2,6-dione in the presence of a solvent and catalyst to obtain pomalidomide
Implementation Method 4
a purification method using solvent and anti-solvent to achieve high yield and purity greater than 99%
Implementation Method 5
The process also results in a high yield, is simple, cost effective, and feasible for large scale production
Data Source
Figure 1
AI summary
Methods of synthesizing pomalidomide are disclosed. Further, methods of purifying pomalidomide from a reaction mixture are also disclosed.